Identification and Functional Characterization of the Human Glutathione S-Transferase P1 Gene as a Novel Transcriptional Target of the p53 Tumor Suppressor Gene
The glutathione S -transferase P1 (GSTP1) is involved in multiple cellular functions, including phase II metabolism, stress response, signaling, and apoptosis. The mechanisms underlying the significantly high GSTP1 expression in many human tumors are, however, currently not well understood. We repor...
Gespeichert in:
Veröffentlicht in: | Molecular cancer research 2008-05, Vol.6 (5), p.843-850 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The glutathione S -transferase P1 (GSTP1) is involved in multiple cellular functions, including phase II metabolism, stress response, signaling,
and apoptosis. The mechanisms underlying the significantly high GSTP1 expression in many human tumors are, however, currently
not well understood. We report here that the GSTP1 gene is a heretofore unrecognized downstream transcriptional target of the tumor suppressor p53. We identified a p53-binding
motif comprising two consecutive half-sites located in intron 4 of the GSTP1 gene and is highly homologous to consensus p53-binding motifs in other p53-responsive genes. Using a combination of electrophoretic
mobility shift assay and DNase I footprinting analyses, we showed that wild-type p53 protein binds to the GSTP1 p53 motif
and luciferase reporter assays showed the motif to be transcriptionally functional in human tumor cells. In a temperature-sensitive
p53-mutant cells, levels of both p21/WAF1 and GSTP1 gene transcripts increased time dependently when cells were switched from
the inactive mutant state to the wild-type p53 state. Small interfering RNA–mediated reduction of p53 expression resulted
in a specific decrease in GSTP1 expression and in tumor cells with mutated p53; adenovirally mediated expression of wild-type
p53 increased GSTP1 expression significantly. In a panel of early-passage brain tumor cultures from patients, high levels
of GSTP1 transcripts and protein were associated with wild-type p53 and, conversely, low GSTP1 levels with mutant p53. p53
expression knockdown by small interfering RNA increased cisplatin sensitivity. The ability of wild-type p53 to transcriptionally
activate the human GSTP1 gene defines a novel mechanism of protecting the genome and, potentially, of tumor drug resistance. (Mol Cancer Res 2008;6(5):843–50) |
---|---|
ISSN: | 1541-7786 1557-3125 |
DOI: | 10.1158/1541-7786.MCR-07-2105 |